Stratton Management’s Bristol-Myers Squibb BMY Stock Holding History

Stratton Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$12.3M	Sell	179,454 -17,675	-9%	-$1.17M	1.5%	11
2015 Q3	$11.7M	Buy	197,129 +21,261	+12%	+$1.35M	1.34%	15
2015 Q2	$11.7M	Sell	175,868 -7,700	-4%	-$507K	0.51%	68
2015 Q1	$11.8M	Buy	183,568 +550	+0.3%	+$34.4K	0.48%	75
2014 Q4	$10.8M	Buy	183,018 +12,720	+7%	+$717K	0.44%	82
2014 Q3	$8.72M	Sell	170,298 -15,940	-9%	-$796K	0.39%	88
2014 Q2	$9.03M	Sell	186,238 -21,300	-10%	-$1.05M	0.38%	94
2014 Q1	$10.8M	Sell	207,538 -1,520	-0.7%	-$80.9K	0.5%	74
2013 Q4	$11.1M	Sell	209,058 -13,710	-6%	-$698K	0.53%	67
2013 Q3	$10.3M	Buy	222,768 +9,758	+5%	+$428K	0.53%	68
2013 Q2	$9.52M	Buy	+213,010	New	+$9.25M	0.55%	67

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Stratton Management's BMY Position: Q4 2015 in Review

Stratton Management reduced its Bristol-Myers Squibb (BMY) stake by 9% in Q4 2015, selling an estimated $1.17M and leaving 179,454 shares worth $12.3M. The position accounts for 1.5% of the portfolio, ranked #11.

Stratton Management first reported a position in BMY in Q2 2013 and has held it in 11 quarters since. 1,535 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Stratton Management held 179,454 shares of Bristol-Myers Squibb worth $12.3M as of Q4 2015.
Stratton Management sold 17,675 Bristol-Myers Squibb shares in Q4 2015, an estimated $1.17M.
Bristol-Myers Squibb made up 1.5% of Stratton Management's portfolio in Q4 2015, its #11 holding.
Stratton Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 11 quarters since.
1,535 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.